Clinical trial

Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma

NCT00188929 · University Health Network, Toronto, Other · Completed

Key facts

NCT number NCT00188929
Title Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's Lymphoma
Official title Spatio-temporal Response of Non-Hodgkin's Lymphoma to External Beam Radiation Therapy Measuring 18F-Fluorodeoxyglucose (FDG) Uptake Using a Combined PET/CT Scanner: A Pilot Study
Lead sponsor University Health Network, Toronto, Other
Collaborators Princess Margaret Hospital, Canada
Status Completed
Phase Phase 2
Study type Interventional
Conditions Lymphoma, Non-Hodgkin
Intervention type Procedure
Interventions PET Scan with [18F]Fluoro-2-deoxyglucose (FDG)
Enrollment 10
Start date Aug 1, 2005
Primary completion Jul 1, 2009
Completion Jul 1, 2009
First posted Sep 16, 2005
Last update posted Aug 13, 2010
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies